EntryPoint Capital »

ACADIA Pharmaceuticals shares owned by EntryPoint Capital

Quarter-by-quarter ownership of ACADIA Pharmaceuticals (ACAD) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in ACADIA Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including ACADIA Pharmaceuticals held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ACADIA Pharmaceuticals by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $121k 7.4k 16.25

More positions owned by EntryPoint Capital

Global Ship Lease Com Cl A (GSL)
Delek Us Holdings (DK)
CoStar (CSGP)
Vista Energy S.a.b. De C.v. Sponsored Ads (VIST)
Skechers U S A Cl A (SKX)
Nextera Energy Partners Com Unit Part In (NEP)
Alerus Finl (ALRS)
Liveramp Holdings (RAMP)
Trimas Corp Com New (TRS)
Cbl & Assoc Pptys Common Stock (CBL)
Rockwell Automation (ROK)
Illinois Tool Works (ITW)
National Fuel Gas (NFG)
EastGroup Properties (EGP)
Hologic (HOLX)

View all positions for EntryPoint Capital

Top funds holding ACADIA Pharmaceuticals

Baker Bros. Advisors
Vanguard Group
BlackRock
State Street Corporation
Point72 Asset Management
Millennium Management
D. E. Shaw & Co
Geode Capital Management
Marshall Wace
Fred Alger Management
Palo Alto Investors
Morgan Stanley
Voloridge Investment Management
Goldman Sachs Group
Tang Capital Management

View all funds holding ACADIA Pharmaceuticals